Wyoming Medicaid Becomes First State to Cover Cognoa’s Canvas Dx, Expanding Access to Early Autism Diagnosis

Cognoa, a leading child development and behavioral health company, announced its inclusion as a covered benefit under;Wyoming Medicaid;that will cover the cost of the company's flagship product, Canvas Dx – the first FDA-authorized diagnostic for children at risk of developmental delays including autism.;Wyoming's;coverage of AI-based Canvas Dx sets a powerful precedent for other states as a key step to making early detection of autism and subsequent early support and services a reality for all children in need.

By introducing Canvas Dx as a covered benefit, it is now easier . . .